246 related articles for article (PubMed ID: 21911917)
1. NUAK2: an emerging acral melanoma oncogene.
Namiki T; Coelho SG; Hearing VJ
Oncotarget; 2011 Sep; 2(9):695-704. PubMed ID: 21911917
[TBL] [Abstract][Full Text] [Related]
2. Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas.
Nojima K; Hayashi M; Tanemura A; Al-Busani H; Saito T; Suzuki T; Ishikawa M; Mori T; Wada S; Yamazaki N; Katayama I; Mori H; Yokozeki H; Okiyama N; Sasaki Y; Namiki T
Pigment Cell Melanoma Res; 2024 Jan; 37(1):36-44. PubMed ID: 37596787
[TBL] [Abstract][Full Text] [Related]
3. NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation.
Namiki T; Yaguchi T; Nakamura K; Valencia JC; Coelho SG; Yin L; Kawaguchi M; Vieira WD; Kaneko Y; Tanemura A; Katayama I; Yokozeki H; Kawakami Y; Hearing VJ
Cancer Res; 2015 Jul; 75(13):2708-15. PubMed ID: 25832654
[TBL] [Abstract][Full Text] [Related]
4. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.
Namiki T; Tanemura A; Valencia JC; Coelho SG; Passeron T; Kawaguchi M; Vieira WD; Ishikawa M; Nishijima W; Izumo T; Kaneko Y; Katayama I; Yamaguchi Y; Yin L; Polley EC; Liu H; Kawakami Y; Eishi Y; Takahashi E; Yokozeki H; Hearing VJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6597-602. PubMed ID: 21460252
[TBL] [Abstract][Full Text] [Related]
5. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
Ashida A; Takata M; Murata H; Kido K; Saida T
Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.
Puig-Butillé JA; Badenas C; Ogbah Z; Carrera C; Aguilera P; Malvehy J; Puig S
Exp Dermatol; 2013 Feb; 22(2):148-50. PubMed ID: 23362874
[TBL] [Abstract][Full Text] [Related]
7. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
8. Specific dermoscopy patterns and amplifications of the cyclin D1 gene to define histopathologically unrecognizable early lesions of acral melanoma in situ.
Yamaura M; Takata M; Miyazaki A; Saida T
Arch Dermatol; 2005 Nov; 141(11):1413-8. PubMed ID: 16301388
[TBL] [Abstract][Full Text] [Related]
9. Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
Haugh AM; Zhang B; Quan VL; Garfield EM; Bubley JA; Kudalkar E; Verzi AE; Walton K; VandenBoom T; Merkel EA; Lee CY; Tan T; Isales MC; Kong BY; Wenzel AT; Bunick CG; Choi J; Sosman J; Gerami P
J Invest Dermatol; 2018 Feb; 138(2):384-393. PubMed ID: 28870692
[TBL] [Abstract][Full Text] [Related]
10. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin.
Bastian BC; Kashani-Sabet M; Hamm H; Godfrey T; Moore DH; Bröcker EB; LeBoit PE; Pinkel D
Cancer Res; 2000 Apr; 60(7):1968-73. PubMed ID: 10766187
[TBL] [Abstract][Full Text] [Related]
11. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
12. Targeted Genomic Profiling of Acral Melanoma.
Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 is a candidate oncogene in cutaneous melanoma.
Sauter ER; Yeo UC; von Stemm A; Zhu W; Litwin S; Tichansky DS; Pistritto G; Nesbit M; Pinkel D; Herlyn M; Bastian BC
Cancer Res; 2002 Jun; 62(11):3200-6. PubMed ID: 12036934
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
15. Oncogene-induced senescence and melanoma: where do we stand?
Peeper DS
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1107-11. PubMed ID: 22018309
[TBL] [Abstract][Full Text] [Related]
16. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
[TBL] [Abstract][Full Text] [Related]
17. Somatic activation of KIT in distinct subtypes of melanoma.
Curtin JA; Busam K; Pinkel D; Bastian BC
J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
[TBL] [Abstract][Full Text] [Related]
18. Mutational status of naevus-associated melanomas.
Shitara D; Tell-Martí G; Badenas C; Enokihara MM; Alós L; Larque AB; Michalany N; Puig-Butille JA; Carrera C; Malvehy J; Puig S; Bagatin E
Br J Dermatol; 2015 Sep; 173(3):671-80. PubMed ID: 25857817
[TBL] [Abstract][Full Text] [Related]
19. Identification of anaplastic lymphoma kinase break points and oncogenic mutation profiles in acral/mucosal melanomas.
Niu HT; Zhou QM; Wang F; Shao Q; Guan YX; Wen XZ; Chen LZ; Feng QS; Li W; Zeng YX; Zhang XS
Pigment Cell Melanoma Res; 2013 Sep; 26(5):646-53. PubMed ID: 23751074
[TBL] [Abstract][Full Text] [Related]
20. Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.
Wang M; Banik I; Shain AH; Yeh I; Bastian BC
Genome Med; 2022 Jun; 14(1):65. PubMed ID: 35706047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
